Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The result is decreased caloric intake and faster weight losstypically visible within weeks rather than months
In fact, the term GLP-1 drug itself is becoming somewhat restrictive as researchers create drugs targeting other incretin hormones
Additionally, any drug development for PWS will need to address the complexities of the syndrome, which includes not only hyperphagia and obesity but also developmental issues, psychiatric conditions, and endocrine disorders
DOI: doi.org/10.1101/2025.10.15.682610 Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands Williams TL, Macrae RGC, Kuc RE, Brown AJH, Maguire JJ, Davenport AP
US$ 22.69
US$ 20.19
US$ 28.31
US$ 29.76
